Xinfeng Wang

发表

Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state

Jiagen Li, N. Sun, Jie He, 2020, Cancer science.

Survival-associated alternative splicing signatures in esophageal carcinoma

Jiagen Li, N. Sun, Ning Li, 2018, Carcinogenesis.

Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma

Jiagen Li, N. Sun, Ning Li, 2020, Cellular Oncology.

Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma.

N. Sun, Jie He, Runsen Jin, 2020, Cancer letters.

KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

N. Sun, Q. Xue, Yan Wang, 2022, Cancer communications.

Detection of somatic mutations in circulating cell-free DNA from patients with esophageal squamous cell carcinoma

F. Tan, Q. Xue, Jie He, 2020 .

Multiregion sequencing reveals the genetic correlation of esophageal squamous cell carcinoma and matched cell-free DNA

F. Tan, Q. Xue, Jie He, 2020 .

Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review

X. Bao, Dan Zhang, Zhenhua Zhao, 2020, Cancer Immunology, Immunotherapy.

S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis

N. Sun, Jie He, Zhiliang Lu, 2021, Clinical and translational medicine.

Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response.

Jiagen Li, N. Sun, Ning Li, 2019, Cancer letters.

Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

N. Sun, F. Tan, Q. Xue, 2022, Frontiers in Immunology.

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.

N. Sun, Jie He, Zhiliang Lu, 2020, Cancer letters.

Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma

N. Sun, Jie He, Sufei Zheng, 2021, Therapeutic advances in medical oncology.

A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma

N. Sun, Jie He, Yuanyuan Lei, 2021, Cancer biology & medicine.

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?

F. Tan, Q. Xue, Jie He, 2020, Cancer communications.

Genomic Determinants of Homologous Recombination Deficiency across Human Cancers

L. Ding, L. Pusztai, T. Qing, 2021, Cancers.

Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report

N. Sun, Ning Li, Jie He, 2019, Cellular Oncology.

Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.

F. Tan, Q. Xue, Jie He, 2021, Cancer genetics.

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer

N. Sun, Jie He, Runsen Jin, 2020, Cancer biology & medicine.

Xiaoguang Chen, Huijuan Zhu, Zhengyi Zhao, 2021, Frontiers in Oncology.

Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer

N. Sun, Jie He, Y. Che, 2020, Clinical and translational medicine.

Aneuploid circulating tumor endothelial cells (CTECs) affect the detection of CTC, but they are fundamentally different

N. Sun, Jie He, Y. Che, 2020 .

PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing

N. Sun, Jie He, Y. Che, 2019, Cancer medicine.

A case of pembrolizumab-induced fulminant Type 1 diabetes mellitus in breast cancer.

W. Zuo, Zhengyi Zhao, T. Yuan, 2021, Immunotherapy.

Weighted gene co-expression network analysis identifies key hub genes and pathways in acute myeloid leukemia

D. Ashbrook, A. Bajpai, A. Starlard-Davenport, 2023, Frontiers in Genetics.

The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer

N. Sun, Jie He, Y. Che, 2020, Cell death & disease.

Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity

N. Sun, F. Zhou, Jianbing Huang, 2019, Journal of Translational Medicine.

Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection

N. Sun, F. Zhou, Jie He, 2019, Oncoimmunology.

Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer

N. Sun, Jie He, Zhiliang Lu, 2020, Journal of experimental & clinical cancer research : CR.

Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1

N. Sun, Jie He, Zhiliang Lu, 2021, Translational lung cancer research.

ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells

N. Sun, Jie He, Y. Che, 2020, Cell Death & Disease.

Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity

N. Sun, F. Zhou, Jie He, 2019, Journal of Translational Medicine.

The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non‐small‐cell lung cancer

N. Sun, Jie He, Y. Che, 2021, Clinical & translational immunology.

The Superior Efficacy of Anti-PD-1/PD-L1 Immunotherapy in KRAS-Mutant Non-Small Cell Lung Cancer that Correlates with an Inflammatory Phenotype and Increased Immunogenicity

N. Sun, Jie He, Zhiliang Lu, 2019, SSRN Electronic Journal.

The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis

N. Sun, Jie He, Zhiliang Lu, 2019, Front. Oncol..

Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report

N. Sun, Ning Li, Y. Che, 2019, Cellular Oncology.